283 related articles for article (PubMed ID: 32758279)
21. Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.
Styliara EI; Astrakas LG; Alexiou G; Xydis VG; Zikou A; Kafritsas G; Voulgaris S; Argyropoulou MI
Curr Oncol; 2024 Apr; 31(4):2233-2243. PubMed ID: 38668068
[No Abstract] [Full Text] [Related]
22. Deriving quantitative information from multiparametric MRI via Radiomics: Evaluation of the robustness and predictive value of radiomic features in the discrimination of low-grade versus high-grade gliomas with machine learning.
Ubaldi L; Saponaro S; Giuliano A; Talamonti C; Retico A
Phys Med; 2023 Mar; 107():102538. PubMed ID: 36796177
[TBL] [Abstract][Full Text] [Related]
23. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
Li Y; Liang Y; Sun Z; Xu K; Fan X; Li S; Zhang Z; Jiang T; Liu X; Wang Y
Neuroradiology; 2019 Nov; 61(11):1229-1237. PubMed ID: 31218383
[TBL] [Abstract][Full Text] [Related]
24. Radiomic analysis of multi-contrast brain MRI for the prediction of survival in patients with glioblastoma multiforme.
Chaddad A; Desrosiers C; Toews M
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():4035-4038. PubMed ID: 28325002
[TBL] [Abstract][Full Text] [Related]
25. Survival-relevant high-risk subregion identification for glioblastoma patients: the MRI-based multiple instance learning approach.
Zhang X; Lu D; Gao P; Tian Q; Lu H; Xu X; He X; Liu Y
Eur Radiol; 2020 Oct; 30(10):5602-5610. PubMed ID: 32417949
[TBL] [Abstract][Full Text] [Related]
26. A Multi-parametric MRI-Based Radiomics Signature and a Practical ML Model for Stratifying Glioblastoma Patients Based on Survival Toward Precision Oncology.
Osman AFI
Front Comput Neurosci; 2019; 13():58. PubMed ID: 31507398
[No Abstract] [Full Text] [Related]
27. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques.
Bathla G; Priya S; Liu Y; Ward C; Le NH; Soni N; Maheshwarappa RP; Monga V; Zhang H; Sonka M
Eur Radiol; 2021 Nov; 31(11):8703-8713. PubMed ID: 33890149
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of supratentorial single brain metastasis and glioblastoma by using peri-enhancing oedema region-derived radiomic features and multiple classifiers.
Dong F; Li Q; Jiang B; Zhu X; Zeng Q; Huang P; Chen S; Zhang M
Eur Radiol; 2020 May; 30(5):3015-3022. PubMed ID: 32006166
[TBL] [Abstract][Full Text] [Related]
29. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
30. MRI-based machine learning for determining quantitative and qualitative characteristics affecting the survival of glioblastoma multiforme.
Jajroudi M; Enferadi M; Homayoun AA; Reiazi R
Magn Reson Imaging; 2022 Jan; 85():222-227. PubMed ID: 34687850
[TBL] [Abstract][Full Text] [Related]
31. Overall survival prediction in glioblastoma multiforme patients from volumetric, shape and texture features using machine learning.
Sanghani P; Ang BT; King NKK; Ren H
Surg Oncol; 2018 Dec; 27(4):709-714. PubMed ID: 30449497
[TBL] [Abstract][Full Text] [Related]
32. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
[TBL] [Abstract][Full Text] [Related]
33. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
34. DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique.
Dehkordi ANV; Kamali-Asl A; Wen N; Mikkelsen T; Chetty IJ; Bagher-Ebadian H
NMR Biomed; 2017 Sep; 30(9):. PubMed ID: 28543885
[TBL] [Abstract][Full Text] [Related]
35. Reliability of tumor segmentation in glioblastoma: Impact on the robustness of MRI-radiomic features.
Tixier F; Um H; Young RJ; Veeraraghavan H
Med Phys; 2019 Aug; 46(8):3582-3591. PubMed ID: 31131906
[TBL] [Abstract][Full Text] [Related]
36. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.
Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA
J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245
[TBL] [Abstract][Full Text] [Related]
37. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
38. Radiomic features and multilayer perceptron network classifier: a robust MRI classification strategy for distinguishing glioblastoma from primary central nervous system lymphoma.
Yun J; Park JE; Lee H; Ham S; Kim N; Kim HS
Sci Rep; 2019 Apr; 9(1):5746. PubMed ID: 30952930
[TBL] [Abstract][Full Text] [Related]
39. Machine learning based on multi-parametric magnetic resonance imaging to differentiate glioblastoma multiforme from primary cerebral nervous system lymphoma.
Nakagawa M; Nakaura T; Namimoto T; Kitajima M; Uetani H; Tateishi M; Oda S; Utsunomiya D; Makino K; Nakamura H; Mukasa A; Hirai T; Yamashita Y
Eur J Radiol; 2018 Nov; 108():147-154. PubMed ID: 30396648
[TBL] [Abstract][Full Text] [Related]
40. Improving radiomic model reliability using robust features from perturbations for head-and-neck carcinoma.
Teng X; Zhang J; Ma Z; Zhang Y; Lam S; Li W; Xiao H; Li T; Li B; Zhou T; Ren G; Lee FK; Au KH; Lee VH; Chang ATY; Cai J
Front Oncol; 2022; 12():974467. PubMed ID: 36313629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
